Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial
An error appeared in the “corrected proof” publication of this article [Merat S and the SD1000 Research Team. SD1000: High Sustained Viral Response Rate in 1361